Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications
- PMID: 20125024
- DOI: 10.1097/MOO.0b013e32833693e7
Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications
Abstract
Purpose of review: Chemoradiation has become a common approach in the treatment of advanced head and neck cancer. Its effectiveness in eradicating associated nodal metastases has resulted in modifications in the traditional paradigms for managing this aspect.
Recent findings: Regardless of the pretreatment neck staging, patients who have a complete response to chemoradiation are unlikely to have residual viable tumor in this region, thus putting in question the need for planned neck dissection. F-Fluorodeoxyglucose positron emission tomography/computed tomography has become a standard tool to assess disease response to chemoradiotherapy, including the associated nodal disease. However, there remains an ongoing debate about its timing. The extent of neck dissection is trending toward an approach for selective procedures in order to minimize the long-term sequelae of extensive neck fibrosis.
Summary: Post-chemoradiotherapy neck dissection is an effective procedure for selected patients with advanced head and neck cancer but is becoming a less needed intervention.
Similar articles
-
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40. doi: 10.1001/archotol.133.5.435. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17515501
-
Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.Laryngoscope. 2009 Nov;119(11):2150-5. doi: 10.1002/lary.20523. Laryngoscope. 2009. PMID: 19544378
-
PET monitoring of therapy response in head and neck squamous cell carcinoma.J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20. J Nucl Med. 2009. PMID: 19380408 Review.
-
Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1418-23. doi: 10.1016/j.ijrobp.2003.09.004. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050318
-
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.Oral Oncol. 2012 Mar;48(3):203-10. doi: 10.1016/j.oraloncology.2011.10.015. Epub 2011 Nov 21. Oral Oncol. 2012. PMID: 22104248 Review.
Cited by
-
Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma.Cancers (Basel). 2021 May 18;13(10):2457. doi: 10.3390/cancers13102457. Cancers (Basel). 2021. PMID: 34070089 Free PMC article.
-
Neck management in head and neck squamous cell carcinomas: where do we stand?Med Oncol. 2019 Mar 27;36(5):40. doi: 10.1007/s12032-019-1265-1. Med Oncol. 2019. PMID: 30919135 Review.
-
Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary.Strahlenther Onkol. 2024 Jul;200(7):553-567. doi: 10.1007/s00066-024-02228-4. Epub 2024 Apr 10. Strahlenther Onkol. 2024. PMID: 38600366 Review.
-
A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives.Indian J Palliat Care. 2012 May;18(2):87-97. doi: 10.4103/0973-1075.100820. Indian J Palliat Care. 2012. PMID: 23093823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials